Serum Levels of Soluble Intercellular Adhesion Molecule-1 and Soluble Vascular Cell Adhesion Molecule-1 in Liver Disease,and Their Changes by Treatment with Interferon
Restricted accessResearch articleFirst published online May, 1996
Serum Levels of Soluble Intercellular Adhesion Molecule-1 and Soluble Vascular Cell Adhesion Molecule-1 in Liver Disease,and Their Changes by Treatment with Interferon
Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were measured by an enzyme-linked immunosorbent assay in patients with chronic hepatitis (n = 57), liver cirrhosis (n = 19) and hepatocellular carcinoma (n = 33). Serum levéis of sICAM-1 and sVCAM-1 were significantly higher in liver disease than those in controls (P < 0.0001 and P < 0.0005, respectively). A total of 22 patients with chronic hepatitis C were treated with interferon. Pretreatment levels of sICAM-1 and sVCAM-1 were not significantly different between complete responders and non-responders. In complete responders, serum sICAM-1 and sVCAM-1 levels 1 year after interferon treatment significantly decreased compared to the pretreatment levels (P < 0.005 and P < 0.05, respectively). Post-treatment levels of sICAM-1 and sVCAM-1 in complete responders were also significantly lower than those in non-responders (P < 0.005 and P < 0.05, respectively). This suggests that monitoring soluble adhesion molecules might be useful in the follow-up of patients with liver disease.
VolpesRvan Den OordJJDesmetVJ: Immunohistochemical study of adhesion molecules in liver inflammation. Hepatology1990; 12: 59–65.
2.
VolpesRvan Den OordJJDesmetVJ: Vascular adhesion molecules in acute and chronic liver inflammation. Hepatology1992; 15: 269–275.
3.
HyodoIJinnoKTanimizuM: Detection of circulating intercellular adhesion molecule-1 in hepatocellular carcinoma. Int J Cancer1993; 55: 775–779.
4.
ToriiAHaradaANakaoA: Expression of intercellular adhesion molecule-1 in hepatocellular carcinoma. J Surg Oncol1993; 53: 239–242.
5.
AdamsDHMainolfiEBurraP: Detection of circulating intercellular adhesion molecule-1 in chronic liver diseases. Hepatology1992; 16: 810–814.
6.
HoriikeNOnjiMKumamatoI: Soluble intercellular adhesion molecule-1 in serum in chronic hepatitis B and C. J Gastroenterol1994; 29: 455–459.
7.
LimAGJazrawiRPAhmedHA: Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: relationship with disease stage, immune activity and cholestasis. Hepatology1994; 20: 882–888.
8.
AdamsDHBurraPHubscherSG: Endothelial activation and circulating vascular adhesion molecules in alcoholic liver disease. Hepatology1994; 19: 588–594.
9.
LimAGJazrawiRPLevyJH: Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosis. J Hepatol1995; 22: 416–422.
10.
AdamsDHHubscherSGShawJ: Increased expression of intercellular adhesion molecule-1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology1991; 14: 426–431.
11.
HoriikeNOnjiMKumonI: Intercellular adhesion molecule-1 expression on the hepatocyte membrane of patients with chronic hepatitis B and C. Liver1993; 13: 10–14.
12.
DoiTYamadaGMizunoM: Immunohistochemical study of the distribution of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in chronic type B hepatitis. J Gastroenterol1994; 29: 164–171.
13.
HuKQYuCHVierlingJM: Up-regulation of intercellular adhesion molecule 1 transcription by hepatitis B virus X protein. Proc Natl Acad Sci USA1992; 89: 11441–11445.
14.
RothleinRMainolfiEACzajkowskiM: A form of circulating ICAM-1 in human serum. J Immunol1991; 147: 3788–3793.
15.
De FougerollesARStackerSASchwartingR: Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1. J Exp Med1991; 174: 253–267.
16.
NakamuraSOhtaniHWatanabeY: In situ expression of the cell adhesion molecules in inflammatory bowel disease. Lab Invest1993; 69: 77–85.
17.
MaedaKKosco-VilboisMHBurtonGF: Expression of the intercellular adhesion molecule-1 on high endothelial venules and on non-lymphoid antigen handling cells: interdigitating cells, antigen transporting cells and follicular dendritic cells. Cell Tissue Res1995; 279: 47–54.
18.
van Den OordJJVolpesRDesmetVJ: Dendritic cells and the liver. APMIS1991; 23: 68–76.
19.
KumonI: In situ characterization of mononuclear cell phenotype in intrahepatic lymphoid follicles in patients with chronic viral hepatitis. Gastroenterol Jpn1992; 27: 638–645.
20.
MosnierJFDegottCMarcellinP: The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology1993; 17: 366–371.
21.
MosnierJFScoazecJYMarcellinP: Expression of cytokine-dependent immune adhesion molecules by hepatocytes and bile duct cells in chronic hepatitis C. Gastroenterology1994; 107: 1457–1468.
22.
PirisiMFalletiEFabrisC: Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease; Relationship with cholestasis and functioning hepatic mass. Am J Clin Pathol1994; 102: 600–604.
23.
Nouri-AriaKTKoskinasJTibbsCJ: Serum intercellular adhesion molecule-1 levels in chronic hepatitis C: association with disease activity and response to interferonα. Gut1995; 36: 599–603.
24.
García-MonzónCGarcía-BueyLGarcía-SánchezA: Down-regulation of intercellular adhesion molecule 1 on hepatocytes in viral chronic hepatitis treated with interferon alfa-2b. Gastroenterology1993; 105: 462–469.
25.
EguchiKKawakamiANakashimaM: Interferon-alpha and dexamethasone inhibit adhesion of T cells to endothelial cells and synovial cells. Clin Exp Immunol1992; 88: 448–454.
26.
García-MonzónCSánchez-MadridFGarcía-BueyL: Vascular adhesion molecule expression in viral chronic hepatitis: evidence of neoangiogenesis in portal tract. Gastroenterology1995; 108: 231–241.
27.
TsujisakiMImaiKHirataH: Detection of circulating intercellular adhesion molecule-1 antigen in malignant diseases. Clin Exp Immunol1991; 85: 3–8.
